Immunotherapy in NMSC: Challenges in CSCC and BCC

Activity Overview

This 15-minute gamified activity features an interactive, escape-room approach to learning bite-sized information related to evidence-based strategies for integrating immunotherapy in the management of advanced cutaneous squamous cell carcinoma (CSCC) and basal cell carcinoma (BCC).

0.25 CE Credit(s)
Expires: January 15, 2024

Target Audience

Medical oncology and dermatology clinicians

Learning Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Assess current clinical evidence for immunotherapy-based treatment of advanced nonmelanoma skin cancer (NMSC)
  • Integrate immunotherapy in the management of advanced cutaneous squamous cell carcinoma (CSCC) and basal cell carcinoma (BCC)

Activity Faculty

Nikhil I. Khushalani, MD (Chair)

Nikhil I. Khushalani, MD (Chair)

Vice Chair and Senior Member
Department of Cutaneous Oncology
Moffitt Cancer Center
Tampa, FL

Provider Statement

This activity is provided by RMEI Medical Education, LLC

Supporter Statement

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Subscribe

Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources